Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Mitobe

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Anticancer Research|February 28, 2023
Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to TemozolomideYurika Nakagawa-Saito, Yuta Mitobe, Keita Togashi, et al.
Nursing Reports (Pavia, Italy)|November 22, 2022
Perspectives on Collaboration between Physicians and Nurse Practitioners in Japan: A Cross-Sectional StudyMari Igarashi, Ryuichi Ohta, Akinori Nakata, et al.
Surgical Neurology International|April 17, 2024
Association of ADC of hyperintense lesions on FLAIR images with TERT promoter mutation status in glioblastoma IDH wild typeShigeru Kamimura, Yuta Mitobe, Kazuki Nakamura, et al.
Biomedicines|July 29, 2023
The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In VivoYuta Mitobe, Shuhei Suzuki, Yurika Nakagawa-Saito, et al.
Nutrients|October 31, 2018
Micronutrient Status in Sri Lanka: A ReviewHansani Madushika Abeywickrama, Yu Koyama, Mieko Uchiyama, et al.
International Journal of Molecular Sciences|July 28, 2022
HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated ProgenyYurika Nakagawa-Saito, Shinichi Saitoh, Yuta Mitobe, et al.
Cancers|September 9, 2023
Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor CellsYuta Mitobe, Shuhei Suzuki, Yurika Nakagawa-Saito, et al.
Cancers|January 11, 2024
CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma CellsKeita Togashi, Shuhei Suzuki, Yuta Mitobe, et al.
Journal of Clinical Medicine|April 30, 2021
Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver DiseaseKazuki Ohashi, Toru Ishikawa, Asami Hoshii, et al.
Anticancer Research|October 3, 2022
CEP-1347 Targets MDM4 Protein Expression to Activate p53 and Inhibit the Growth of Glioma CellsYuta Mitobe, Yurika Nakagawa-Saito, Keita Togashi, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Anticancer Research|February 28, 2023
Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to TemozolomideYurika Nakagawa-Saito, Yuta Mitobe, Keita Togashi, et al.
Nursing Reports (Pavia, Italy)|November 22, 2022
Perspectives on Collaboration between Physicians and Nurse Practitioners in Japan: A Cross-Sectional StudyMari Igarashi, Ryuichi Ohta, Akinori Nakata, et al.
Surgical Neurology International|April 17, 2024
Association of ADC of hyperintense lesions on FLAIR images with TERT promoter mutation status in glioblastoma IDH wild typeShigeru Kamimura, Yuta Mitobe, Kazuki Nakamura, et al.
Biomedicines|July 29, 2023
The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In VivoYuta Mitobe, Shuhei Suzuki, Yurika Nakagawa-Saito, et al.
Nutrients|October 31, 2018
Micronutrient Status in Sri Lanka: A ReviewHansani Madushika Abeywickrama, Yu Koyama, Mieko Uchiyama, et al.
International Journal of Molecular Sciences|July 28, 2022
HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated ProgenyYurika Nakagawa-Saito, Shinichi Saitoh, Yuta Mitobe, et al.
Cancers|September 9, 2023
Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor CellsYuta Mitobe, Shuhei Suzuki, Yurika Nakagawa-Saito, et al.
Cancers|January 11, 2024
CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma CellsKeita Togashi, Shuhei Suzuki, Yuta Mitobe, et al.
Journal of Clinical Medicine|April 30, 2021
Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver DiseaseKazuki Ohashi, Toru Ishikawa, Asami Hoshii, et al.
Anticancer Research|October 3, 2022
CEP-1347 Targets MDM4 Protein Expression to Activate p53 and Inhibit the Growth of Glioma CellsYuta Mitobe, Yurika Nakagawa-Saito, Keita Togashi, et al.
Pageof 5